Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

300 results about "Bone resorption" patented technology

Bone resorption is resorption of bone tissue, that is, the process by which osteoclasts break down the tissue in bones and release the minerals, resulting in a transfer of calcium from bone tissue to the blood.

Strain for improving bone health and application thereof

The invention provides a bacterial strain for improving bone health and application of the bacterial strain. The preservation number of bifidobacterium animalis subsp. Lactis BL-11 is CGMCC (China General Microbiological Culture Collection Center) No.20847. The strain can promote osteoblasts and inhibit osteoclasts in a cell experiment; by constructing a mouse model with abnormal bone growth, the BL-11 probiotics have an obvious improvement effect on bone development indexes of the model mouse, promote bone formation and inhibit bone resorption; furthermore, the BL-11 probiotics can improve the ostealgia score, life quality and bone mineral density of people with osteoporosis or bone mass reduction. The results indicate the application potential of the probiotics in improvement of abnormal bone growth and prevention and treatment of osteoporosis.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD

Application of bifidobacterium animalis subsp. Lactis CP-9 in preparation of product for promoting bone growth and development or improving bone health

The invention provides an application of bifidobacterium animalis subsp. Lactis CP-9 in preparation of a product for promoting bone growth and development or improving bone health. Long-term research and a large number of experiments show that the bifidobacterium animalis subsp. Lactis CP-9 can improve the bone volume fraction, the bone trabecula thickness, the bone density and the bone volume of an organism, and can also effectively improve the growth hormone level and the insulin-like growth factor 1 level, so that bone growth and development are promoted. Meanwhile, the bifidobacterium animalis subsp. Lactis CP-9 can effectively improve the N-terminal propeptide level, osteocalcin level, bone morphogenetic protein level and osteoprotectin level of I-type procollagen in a body, and remarkably reduce the amino-terminal peptide level of the I-type collagen and the ligand level of nuclear factor kappa B receptor activating factor, so that osteoblast differentiation is promoted, osteoclast differentiation is inhibited, and osteoclast differentiation is inhibited. Furthermore, bone formation is promoted, bone resorption is inhibited, bone metabolism is improved, and finally the effect of improving bone health is achieved.
Owner:AUSNUTRIA DAIRY CHINA +1

Polyphenol organic ligand, metal polyphenol nano-particles containing polyphenol organic ligand, and preparation method and application of metal polyphenol nano-particles

The invention provides a compound with a structure as shown in a formula (I). The compound can be used as a polyphenol organic ligand to be self-assembled with metal ions to form metal polyphenol nanoparticles. The nano-particles have a bone targeting effect, are safe, effective, stable and uniform, can realize whole-body transfer, can be degraded in a bone pathology microenvironment, have regulation and control effects on bone resorption and bone formation, can cooperatively regulate and control bone balance, and have a great application prospect in the field of bone diseases such as osteoporosis. # imgabs0 #
Owner:EAST CHINA UNIV OF SCI & TECH

Systems and methods related to intraoral electrical stimulation

An apparatus and method are used to deliver an electrical current to, through or across gingival tissues of a mouth in order to achieve a number of therapeutic, prophylactic, cosmetic, and or regenerative benefits. These benefits include killing or modifying oral microbes, increasing oral vasodilation, reducing oral biofilm, improving blood oral circulation, reversing oral bone resorption, promoting oral osteogenesis, treating gum recession, and fostering gingival regeneration. Other benefits include the treatment of gingivitis, periodontitis, and oral malodor, and other systemic diseases correlated with oral pathogens. Use of systems and methods according to the present invention may effectively tighten epithelial contact with one or more teeth (e.g., by the junctional epithelium and / or the sulcular epithelium) and / or cause a tightening of the oral epithelium, thereby improving an appearance of a human smile.
Owner:BIOLECTRICS

Medicinal and edible composite raw material fermentation product for improving senescence osteoporosis and application of medicinal and edible composite raw material fermentation product

The invention provides a plant lactobacillus TH13, and the preservation number of the plant lactobacillus TH13 is CGMCC (China General Microbiological Culture Collection Center) NO.32112. The plant lactobacillus TH13 provided by the invention can be used for fermenting folium cortex eucommiae and enzymatically hydrolyzed bone meal, and the fermentation product of the plant lactobacillus TH13 has high content of chlorogenic acid, proline, glycine and lysine. The fermentation product can significantly improve the content of alkaline phosphatase (ALP) and osteocalcin (OCN) in mouse serum and reduce the content of tartrate-resistant acid phosphatase (TRACP). Therefore, the fermentation product can significantly improve the bone mineral density of the femur, increase the number of bone trabecula and significantly reduce the separation degree of the bone trabecula, thereby promoting bone formation of a mouse with senile osteoporosis, inhibiting bone resorption and improving senile bone loss and bone microstructure deterioration. The preparation method of the probiotic preparation containing the plant lactobacillus and the probiotic fermentation product is simple, and large-scale production can be realized.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Composite hydrogel as well as preparation method and application thereof

The invention discloses composite hydrogel as well as a preparation method and application thereof, and relates to the technical field of bioactive materials. The composite hydrogel comprises carboxymethyl chitosan, tannic acid and Mn < 2 + >, the mass ratio of the carboxymethyl chitosan to the tannic acid is (5-30): 1. The composite hydrogel has antibacterial and anti-inflammatory effects and good biocompatibility, can construct a good osteogenesis environment, inhibit bone resorption, effectively remove ROS (reactive oxygen species), promote wound healing and improve bone repair efficiency, can release loaded drugs (such as metformin) in a pH-responsive manner, can repair and treat bone defects, and has a good application prospect. The method comprehensively solves various problems of bone defects of old patients, is suitable for preparing bioactive materials, and is used for combined adjuvant therapy of bone defect internal fixation.
Owner:ZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY

Novel immunomodulatory, neuromodulatory, osteogenic and anti-osteoporotic HKUOT-S2 proteins that enhance fracture repair and inhibit osteoporosis development

Provided are compositions comprising a HKUOT-S2 protein, at least one peptide according to at least one of SEQ ID NO: 81-97, or a protein comprising an amino acid sequence according to at least one of SEQ ID NO: 81-97. Methods of osteogenesis are provided, including, for example, methods of enhancing bone repair, modulating polarization of macrophages with proinflammatory and anti-inflammatory activity and bone resorption of osteoclasts, and methods of treating inflammatory diseases, spinal cord injury, liver and kidney diseases, cardiovascular diseases, diabetes, post-menopausal syndrome, infertility, or hematopoietic diseases, or enhancing wound healing.
Owner:THE UNIVERSITY OF HONG KONG

Digital false tooth mounting and positioning device based on three-dimensional scanning and method thereof

The invention relates to the technical field of oral implantation guidance, and provides a digital false tooth mounting and positioning device based on three-dimensional scanning and a method thereof. The method comprises the following steps: scanning the oral cavity of a patient through an oral cavity scanner to generate a three-dimensional oral cavity digital model; generating a virtual implant of the patient and corresponding initial implantation parameters based on the three-dimensional oral cavity digital model through a SegFormer segmentation network; based on historical operation data, initial implantation parameters, bone density, patient attributes and occlusal force parameters, a long sequence prediction network is adopted to predict the position offset and bone resorption degree of the virtual implant after osseointegration through a segmented attention mechanism and a network memory cache mechanism, and optimal implantation parameters are obtained; and pushing a visual dynamic model containing the candidate positioning strategy to the user based on the optimal implantation parameter, driving an oral cavity model printer to obtain an implantation guide plate model and an oral cavity environment model, assisting the user in verifying the installation effect of the candidate positioning strategy, and improving the accuracy of false tooth installation and positioning.
Owner:ZH GRACEFUL DENTAL LAB CO LTD

Composition of salvianolic acid extract and tanshinone extract as well as preparation method, application and product thereof

PendingCN119185399AOrganic active ingredientsSenses disorderDiseaseCardiac edema
The invention provides a composition of a salvianolic acid extract and a tanshinone extract as well as a preparation method, application and a product of the composition, and belongs to the field of medicines. The preparation method of the composition of the salvianolic acid extract and the tanshinone extract comprises steps 1)-4). The composition with carbonic anhydrase inhibitory activity is obtained by extracting the salvianolic acid extract and the tanshinone extract from the radix salviae miltiorrhizae and mixing the salvianolic acid extract and the tanshinone extract, the composition can achieve synergistic interaction, and reference is provided for research and development and component compatibility of medicines mainly comprising the radix salviae miltiorrhizae. The composition provided by the invention can be used for reducing intraocular pressure, inducing diuresis, correcting metabolic acidosis, increasing vascular oxygen flux, improving pulmonary ventilatory capacity, expanding cerebral vessels, inducing tumor cell apoptosis and inhibiting osteoclast bone resorption; the traditional Chinese medicine composition can be used for treating or preventing diseases with intraocular hypertension as symptoms, cardiac edema or acute altitude sickness, cardiovascular and cerebrovascular diseases and bone metabolism diseases caused by osteoporosis.
Owner:ZHEJIANG UNIV

Method and apparatus for constructing microfluidic bone organoid-on-chip

A method for constructing a microfluidic bone organoid-on-chip can continuously observe the impacts of different external factors on a bone tissue structure based on the “ternary regulation theory” of bone angiogenesis-bone resorption-osteogenesis coupling. The method includes: (1) building a visual three-dimensional cell cultivation platform to continuously observe impacts of different external factors on a ternary regulation theory based on angiogenesis of osteoclast precursors, osteoblasts and osteoclasts, such that a user is allowed to directly observe interactions among various kinds of cells; (2) designing microfluidic channels in a chip to allow a reagent involved to present a concentration gradient distribution in the chip; and (3) adding three bioinks including osteoblasts, osteoclasts and vascular endothelial cells respectively, so as to reflect the three cell components individually, in pairs, and as a whole in the chip. An apparatus for constructing a microfluidic bone organoid-on-chip is further provided.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

Application of new target NCSTN for regulating and controlling bone metabolism and agonist of new target NCSTN in preparation of medicine for preventing or treating osteoporosis

The invention belongs to the field of medicines, and particularly relates to application of a new target NCSTN for regulating and controlling bone metabolism and an agonist of the new target NCSTN in preparation of a medicine for preventing or treating osteoporosis. The invention aims to provide a new target NCSTN for regulating and controlling bone metabolism and application of the new target NCSTN in promoting osteogenic activity, inhibiting osteoclast activity and treating osteoporosis. According to the invention, the mechanism of the NCSTN agonist for treating osteoporosis is found for the first time, and the NCSTN agonist has the effects of inhibiting osteoclast maturation and differentiation and promoting osteoblast bone formation function. The mechanism is greatly different from the previously reported mechanism of singly inhibiting bone resorption or singly promoting bone formation, and the osteoporosis treatment which simultaneously acts on bone resorption and bone formation can greatly reduce the adverse reaction of the body to the medicine.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Rhizoma drynariae extracellular vesicle for treating periodontitis by targeting macrophage ETS2 gene as well as preparation method and application of rhizoma drynariae extracellular vesicle

The invention relates to the technical field of biological medicines, in particular to rhizoma drynariae extracellular vesicles for treating periodontitis by targeting macrophage ETS2 genes as well as a preparation method and application of the rhizoma drynariae extracellular vesicles. The extracellular vesicles are creatively extracted from the traditional Chinese medicine rhizoma drynariae by combining a differential ultracentrifugation method with a sucrose density gradient centrifugation method, the functions of the extracellular vesicles are studied, and it is found that the extracellular vesicles can effectively slow down alveolar bone resorption in a periodontitis state and reduce periodontal soft tissue inflammation and have a good treatment effect on periodontitis. It is found for the first time that the rhizoma drynariae extracellular vesicles can reduce the inflammatory ability of macrophages in an inflammatory state and can reduce expression of proinflammatory factors TNF-alpha and IL-6. The invention has important scientific research value and clinical significance for further development and application of various traditional Chinese medicine plant extracellular vesicles including rhizoma drynariae extracellular vesicles.
Owner:HOSPITAL OF STOMATOLOGY GUANGZHOU MEDICAL UNIVERSITY (YANGCHENG HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY)

Application of beta-hydroxybutyric acid in preparation of medicine for preventing and / or treating osteoporosis

The invention relates to the technical field of medicine, in particular to application of beta-hydroxybutyric acid in preparation of medicine for preventing and / or treating osteoporosis, the osteoporosis comprises postmenopausal osteoporosis and diabetic osteoporosis due to estrogen deficiency, the administration concentration of the beta-hydroxybutyric acid is 150mM, and the administration concentration of the beta-hydroxybutyric acid is 10mM. According to the application of the beta-hydroxybutyric acid in preparing the medicine for inhibiting osteoclast differentiation or osteoclast formation, the beta-hydroxybutyric acid inhibits osteoclast precursor cells from being differentiated into osteoclasts, and the administration concentration of the beta-hydroxybutyric acid is 10 mM; the invention proves that the beta-hydroxybutyric acid improves bone microstructures of OVX mice and db / db mice, inhibits osteoclast differentiation and reduces bone resorption, and provides a new target for prevention and treatment of osteoporosis.
Owner:THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIV +1

Injectable double-drug delivery hydrogel and preparation method thereof

The invention discloses injectable double-drug delivery hydrogel and a preparation method thereof, and belongs to the technical field of biomedical materials. According to the method, two nano microspheres with different charges are respectively prepared by utilizing the characteristics of A-type gelatin and B-type gelatin, a negatively charged medicine EGCG is specifically carried by the positively charged A-type gelatin, and a positively charged medicine SAG is carried by the negatively charged B-type gelatin microsphere; and finally, mixing the two gelatin drug-loaded microspheres into a material taking gelatin and zirconium ions as a substrate to form the composite hydrogel. The hydrogel realizes immune regulation and osteogenesis regulation, also realizes long-acting release of the two drugs, effectively solves the problems of bone resorption, difficulty in healing and the like of host tissues through synergistic regulation of inflammation and mobilization of osteogenesis genes, realizes personalized treatment, and improves the clinical treatment effect and efficiency.
Owner:SICHUAN UNIV

Porous-Based Bone Replacement Materials Formed By Triply Periodic Minimal Surface Structure

Porous-based bone implants with the integration of Triply Periodic Minimal Surface, TPMS, porous architectures are designed to support the growth and proliferation of bone tissue, bone marrow, and capillaries. This disclosure intends to reduce the adverse effect of conventional implants such as bone resorption over time, which is called the “stress shielding effect”. The “stress shielding effect” is caused by the mismatch between the implant and natural bone stiffness. Triply Periodic Minimal Surface, TPMS, porous architectures exhibit interconnected pore features. The interconnection of the porous network allows the TPMS to have a higher permeability than that of other porous structures, leading to more favorable nutrient transport. In addition, many physical characteristics of the TPMS structures including surface-to-volume ratio, pore size, elastic modulus, and fluid behaviors can be controlled precisely through mathematical manipulation. As a result, TPMS-based implants could be physical features, which are vaned based on different bone regions. In other words, the medical implants may exhibit non-uniform or gradient physical features, which can match the characteristic of trabecular and cortical bones. Therefore, TPMS-based implants could adjust the features to mimic neighboring bone regions. As a result, we can achieve medical implants, which have superior mechanical and biological responses, resulting in optimal cell growth and better medical treatment.
Owner:PROMOPPATUM PATCHARAPIT

Inorganic ion eluting nanoparticulate mineralized collagen glycosaminoglycan materials

Compositions including a collagen glycosaminoglycan scaffold and a phosphate reservoir material are described. The compositions are useful in methods for promoting osteogenesis and attenuating bone resorption.
Owner:RGT UNIV OF CALIFORNIA +1

Preparation method of skull for autologous replantation

The invention provides a preparation method of a skull for autologous replantation, and relates to the technical field of skull treatment. The method comprises the following steps that the taken-out autologous skull is subjected to ultraviolet radiation and then conveyed into a clean room to be subjected to photographing treatment; sequentially carrying out iodophor soaking, alcohol soaking and normal saline flushing on the skull, and then carrying out surface tissue impurity removal and cleaning on the skull; putting the treated skull into a packaging bag, adding a cryopreservation solution to wrap the skull, and then performing vacuumizing and sealing treatment; and sterilizing and cooling the skull subjected to the sealing treatment, and finally feeding the skull into a bone library for cryopreservation. According to the method, the skull of a patient is taken out after an operation to serve as an autologous bone raw material, so that the skull has bone activity within a certain period of time, finally, the skull is replanted to the skull of the patient, the body burden and conflict psychology of the patient are reduced, the exclusive transportation, treatment and storage modes are adopted, the rejection of the patient is reduced, the risk of bone resorption is reduced, and the bone activity is guaranteed; the replanting rate is increased.
Owner:HONGHU GAOXIANG (BEIJING) BIOTECHNOLOGY CO LTD

Lactobacillus salivarius combination CCFM1398 for regulating and controlling bone homeostasis and relieving bone resorption and metagen of lactobacillus salivarius combination CCFM1398

The invention discloses combined lactobacillus salivarius CCFM1398 for regulating and controlling bone homeostasis and relieving bone resorption and a metagen of the combined lactobacillus salivarius CCFM1398, and belongs to the technical field of microorganisms. The combined lactobacillus salivarius CCFM1398 provided by the invention is separated from oral dental plaque of healthy teenagers, has the effects of relieving bone resorption and resisting inflammation, and is specifically reflected in that expression of protein level and gene level of MC3T3-E1 cell osteoprotegerin (OPG) is improved in vitro; the bone absorption amount of orthodontic bone absorption rat alveolar bone is reduced, the number of alveolar bone osteoclasts is reduced, and the level of rat serum OPG is improved; the secretion of inflammatory factors TNF-alpha, IL-6 and MPO of the orthodontic bone absorption rat is reduced; and the pathological condition of orthodontic bone absorption rat alveolar bone tissue is improved. Therefore, the combined lactobacillus salivarius has a huge application prospect in products for relieving bone resorption and assisting in inhibiting periodontal tissue inflammation.
Owner:JIANGNAN UNIV

Medicine for treating osteoporosis and preparation method thereof

The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating osteoporosis and a preparation method thereof. The medicine for treating osteoporosis is prepared from the following raw materials in parts by weight: 2 to 5 parts of rhizoma gastrodiae, 4 to 10 parts of herba cistanche, 3 to 8 parts of herba epimedii, 2.5 to 6.5 parts of caulis clematidis armandii, 3 to 7 parts of radix rehmanniae, 2 to 4.5 parts of fructus lycii, 5 to 15 parts of radix angelicae sinensis, 8 to 20 parts of radix notoginseng, 4 to 12 parts of rhizoma chuanxiong, 3 to 7 parts of cassia twig, 2 to 5 parts of radix achyranthis bidentatae, 2.5 to 5 parts of colla corii asini, 2 to 4 parts of oyster, 0.5 to 1.5 parts of sesame, 0.1 to 0.3 part of pork liver and 1 to 2.5 parts of roe. The medicine for treating osteoporosis has high content of calcium, phosphorus and vitamin D, absorption and utilization of calcium are promoted, all the preparation raw materials can synergistically regulate bone metabolism, inhibit bone resorption and promote bone formation, then the bone density is increased, and the medicine taking speed is high.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE

Application of D-mannose in preparation of product for treating periodontitis

The invention relates to application of D-mannose in preparation of products for treating periodontitis. The products comprise medicines, daily necessities and foods. The D-mannose provided by the invention can effectively inhibit the alveolar bone resorption of rats induced by LPS, down-regulate the expression of IL-1beta, IL-6, IL-17, TNF-alpha, G-CSF, GM-CSF, MPO, Ly6G, CD11b, TET2, HK1, HK2 and PFPKB3 in rat gingival tissues treated by the LPS, and up-regulate the expression of IL-10. In addition, the D-mannose can also inhibit the activation of neutrophil stimulated by LPS, down-regulate the expression of IL-1beta, IL-6, IL-17 and TET2, and up-regulate the expression of IL-10.
Owner:SHANGHAI STOMATOLOGICAL HOSPITAL FUDAN UNIV

Lactobacillus salivarius combination CCFM1332 with multi-target regulation effect and application of lactobacillus salivarius combination CCFM1332 in periodontitis

The invention discloses combined lactobacillus salivarius CCFM1332 with a multi-target regulation effect and application of the combined lactobacillus salivarius CCFM1332 in periodontitis, and belongs to the technical field of microorganisms. The invention discloses a strain of combined lactobacillus salivarius CCFM1332, and the combined lactobacillus salivarius not only has a vaginal immune regulation effect, but also has an effect of relieving periodontitis, which is specifically embodied in that: the combined lactobacillus salivarius can promote vaginal epithelial cells VK2 / E6E7 to secrete antibacterial peptides; the periodontal probing and diagnosing depth of the periodontitis rats can be reduced; the number of pathogenic bacteria in the oral cavity of the periodontitis rat is reduced; the levels of inflammatory factors IL-1beta, IL-6 and IL-17A in serum are reduced; alveolar bone loss of rats suffering from periodontitis is reduced, and the alveolar bone absorption condition of the rats is effectively relieved.
Owner:JIANGNAN UNIV

Milk protein peptide with effects of promoting calcium absorption and improving bone health and application thereof

The invention provides a milk protein peptide which takes milk protein as a raw material and has the effects of promoting calcium absorption and improving bone health and application of the milk protein peptide. Specifically, milk protein peptide sequences, including YGGVSL and SQRY, are screened by adopting enzymolysis, sequence identification and molecular docking methods. The milk protein peptide is proved to have high calcium transport promoting capacity in the in-vitro intervention of Caco-2 cells, and the milk protein peptide is proved to have the capacity of promoting osteogenesis and inhibiting bone resorption in the in-vitro intervention of MC3T3-E1 mouse embryo osteoblasts. In animal experiments, by increasing the content of blood calcium and bone calcium, reducing the content of excrement calcium, improving mRNA expression of calcium ion channel protein, calcium binding protein and peptide transporter in intestinal tracts, enhancing the efficiency of calcium entering blood, promoting osteogenesis and inhibiting bone resorption, the milk protein peptide is comprehensively proved to have the capabilities of improving calcium resorption of organisms and improving bone health. The milk protein peptide has both functionality and nutrition, and has a wide application prospect in the aspect of bone health.
Owner:CHINA AGRI UNIV +1

Lactobacillus salivarius combination CCFM1397 capable of improving osteoblast activity and relieving bone resorption and periodontal tissue injury and metagen of lactobacillus salivarius combination CCFM1397

The invention discloses a combined lactobacillus salivarius CCFM1397 for improving osteoblast activity and relieving bone resorption and periodontal tissue damage and a metagen thereof, and belongs to the technical field of microorganisms. The lactobacillus salivarius combination CCFM1397 provided by the invention is separated from oral dental plaque of healthy teenagers, has the effects of relieving bone resorption and resisting inflammation, and is specifically reflected in that: the expression of MC3T3-E1 cell osteoprotegerin (OPG) protein and gene level is improved in vitro; the bone absorption amount of orthodontic bone absorption rat alveolar bone is reduced, the number of alveolar bone osteoclasts is reduced, and the level of rat serum OPG is improved; the secretion of inflammatory factors IL-1beta, IL-6 and TNF-alpha and myeloperoxidase MPO of the orthodontic bone absorption rats is reduced; and the pathological condition of orthodontic bone absorption rat alveolar bone tissue is improved. Therefore, the combined lactobacillus salivarius has a huge application prospect in products for relieving bone resorption and assisting in inhibiting periodontal tissue inflammation.
Owner:JIANGNAN UNIV

Wet environment induced adhesion polylipoic acid-based elastic patch as well as preparation method and application thereof

The invention discloses a polylipoic acid-based elastic patch capable of inducing adhesion in a wet environment as well as a preparation method and application of the polylipoic acid-based elastic patch. The polylipoic acid-based elastic adhesion patch can be obtained by simply concentrating and evaporating a mixed solution of lipoic acid and methacrylated gelatin. Due to the introduction of a methacrylated gelatin polymer chain, the layered crystal structure of an original lipoic acid-based polymer is reduced, so that the water sensitivity of the lipoic acid-based polymer is reduced, the release time of lipoic acid active molecules is prolonged, and a small amount of layered crystal structures are reserved in the polylipoic acid-based elastic adhesion patch; therefore, non-adhesion and rigidity are realized in a dry environment. Once exposed to water or body fluid, the hydrophilic polymer backbone of the patch can quickly absorb moisture, the entry of water molecules destroys the layered crystal structure, resulting in softness and adhesion of the patch. In a rat model with ligation of periodontitis, the patch can effectively relieve inflammation and inhibit alveolar bone resorption.
Owner:TIANJIN UNIV

Selenium-based anti-postmenopausal osteoporosis medicine as well as preparation method and application thereof

The invention relates to the technical field of medical preparations, and particularly discloses a selenium-based anti-postmenopausal osteoporosis medicine and a preparation method and application thereof.The selenium-based anti-postmenopausal osteoporosis medicine comprises a main active component, a secondary active component and an auxiliary active component, the main active component is a nano-selenium-phytoestrogen compound and is formed by covalent coupling of selenomethionine and soy isoflavone, the particle size of the main active component is 50-200 nm, and the particle size of the auxiliary active component is 100-200 nm; the mass of the selenium element accounts for 5-30% of the mass of the compound; the auxiliary active component is a collagen peptide-calcium chelate and is prepared from marine collagen peptide and calcium citrate through chelation reaction, and the mass ratio of the calcium element to the collagen peptide is (1: 3)-(1: 5); the targeted delivery carrier is folic acid modified chitosan nanoparticles and is used for loading the main active component and the auxiliary active component; the auxiliary materials comprise a disintegrating agent, a lubricating agent and a pH-sensitive enteric coating material; through the synergistic effect of the main active ingredient nano-selenium-phytoestrogen compound and the auxiliary active ingredient collagen peptide-calcium chelate, bone formation can be promoted and bone resorption can be inhibited at the same time, and dual-function treatment is achieved.
Owner:HUBEI UNIV FOR NATIONALITIES AFFILIATED MINZU UNIV HOSPITAL

Porous Niti alloy bionic bone gradient structure construction method based on 4D printing

The invention relates to the technical field of medical implants, in particular to a 4D printing-based porous Niti alloy bionic bone gradient structure construction method, which comprises the steps of patient bone data acquisition, bionic gradient model design, NiTi powder preparation, 4D printing, thermal treatment activation of memory effect, surface functionalization treatment and mechanical / biological performance test. The method is characterized by comprising the following preparation steps: accurately acquiring bone structure data through CT / MRI, combining Mimics pretreatment and UG / NX modeling, designing aperture and porosity for differentiation of cortical bone (low porosity of 30%-40%) and cancellous bone (high porosity of 50%-70%), simulating typical load working conditions through ANSYS, enabling the elastic modulus (3-15 GPa) and compressive strength (80-200 MPa) to be close to natural bone, and finally obtaining the bone structure data through the CT / MRI, the pore diameter and porosity of the cortical bone (low porosity of 30%-40%) and the porosity of the cancellous bone (high porosity of 50%-70%). According to the design, the elastic modulus difference between the implant and the host bone is remarkably reduced, the bone resorption problem caused by stress shielding is avoided, meanwhile, continuous porosity transition is achieved through the power gradual change technology, and the structural stability under the complex load is improved.
Owner:SHANDONG KANGSHENG MEDICAL EQUIP CO LTD

Application of Trim3 gene and / or expression product thereof in preparation of medicine for treating osteoporosis

The invention discloses application of a Trim3 gene and / or an expression product thereof in preparation of medicines for treating osteoporosis. The over-expression of the Trim3 can improve the bone mineral density of osteoporosis model mice, inhibit bone resorption, inhibit osteoclast differentiation and inflammatory response in vitro, improve osteoporosis and provide a new target for diagnosis and treatment of osteoporosis.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY

Alveolar bone resorption degree detection method, device, equipment and medium

PendingCN121465759AImage enhancementImage analysisExtracted toothTooth enamel
The invention relates to the technical field of oral cavities, and discloses an alveolar bone resorption degree detection method, device and equipment and a medium, oral cavity image data of a patient is obtained, and tooth jaw segmentation data extraction is performed on the oral cavity image data to obtain tooth jaw segmentation data; performing three-dimensional space morphological feature analysis on tooth segmentation data in the tooth jaw segmentation data to obtain tooth coordinate azimuth information; calculating periodontal measurement surface information according to the tooth coordinate azimuth information; extracting enamel boundary line data and alveolar bone boundary line data in the dental jaw segmentation data; calculating an alveolar bone resorption degree result according to the enamel boundary line data, the alveolar bone boundary line data and the periodontal measurement surface information; the alveolar bone resorption degree result is calculated through the boundary line data and the measurement surface information, and the accuracy of the result is improved while the resorption degree is accurately quantified.
Owner:SHENZHEN SAIXI TECHNOLOGY CO LTD

Method for preparing a customized porous tmj prosthesis deposited with europium-doped black phosphorus

The application discloses a preparation method of a customized porous TMJ prosthesis deposited with europium-doped black phosphorus nanosheets, and comprises the following steps: S1, CBCT is used to shoot medical image data, which is imported into Mimics software to reconstruct a model, the reconstructed model is imported into Geomagic software to simulate bone cutting, and a craniofacial model STL file is obtained; S2, TMJ prosthesis customization design is performed on the craniofacial model STL file; S3, SLM printing technology is adopted to perform 3D printing on the customized TMJ prosthesis model, and a prosthesis entity is obtained; and S4, a polydopamine europium-doped black phosphorus nanosheet surface coating is constructed on the porous region of the prosthesis entity model. The application realizes product customization by adopting computer-aided design and three-dimensional printing technology; the europium-doped black phosphorus nanosheet coating is constructed on the porous region of the prosthesis, the mandibular stump and the buccal region are promoted to grow into bone, the traditional "two-dimensional fixation" is changed into "three-dimensional fixation", and the limitation of screw loosening, falling off and bone resorption is got rid of.
Owner:XIAN MEDICAL UNIV